chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up around 3AM in chills and a cold sweat. Was unable to fall back asleep until around 7:30AM--didn't check my temperature until about 8AM, and it was 103.4 degrees. My temperature peaked at 104.1 later that morning. I took Ibuprofen, stayed in bed, kept a cold cloth on my forehead, and drank a lot of water in the meantime. My fever started to come down in the afternoon, but did seem to climb if I wasn't adamant about keeping a cold cloth on my forehead--for example, it would come down to about 100, but if I took of the cloth for about 30 minutes, it started to climb back up toward 102. My fever seemed to break around 4 or 5PM, but I slept most of the day, so I don't have an exact time. After that, I had a little "brain fog" for the rest of the evening (Friday, April 7th), but when I woke Saturday (April 8th) I felt almost totally recovered.
Patient received Moderna COVID vaccine on 7/28/21 (lot # 033C21A), 9/10/21 (lot # 034C21A), and 4/7/22 (lot # 065K21A).  On 11/25/22, patient had a mechanical fall with syncopal episode. On 11/26/22, patient admitted to our inpatient facility (med/surg unit) s/p mechanical fall with acute hypoxic respiratory failure secondary COVID pneumonia and HFrEF, acute metabolic encephalopathy, afib with RVR, and left ankle fracture s/p mechanical fall 11/25. As of today (11/30/22), patient is still admitted in the med/surg unit.
After patient received first dose Pfizer 3ml, Intramuscualr on left deltoid around 1635 on 9/9/2021, patient fainted and seized for about 30 seconds in the COVID shot clinic. When patient regained consciousness he was very pale and lethargic.  Patient was transported to a monitoring room.  Patient's BP was 78/35 HR: 38.  RN started IV and administered NS bolus. EKG was performed. Dextrose 50% in water push was administered batient was observed for about an hour before being discharged at 1735.  Patient's VS improved BP: 121/57 HR: 69. Patient also refused to go to the ER  ***
This is spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration in Jan2021 at single dose for COVID-19 Immunization. Patient took the Pfizer Vaccine. Patient was a senior citizen and a lot of time patient gets diarrhea normally. It was a normal thing if patient eat certain things. So, patient took the vaccine 2 days ago (Jan2021). Now diarrhea was that it pops out. patient did not have that. patient just have a loose bowl movement. So, patient was thinking may be when sometimes patient get diarrhea, patient only eat like bananas and things like that. So, patient definitely want to take the second dose and patient took the first dose 2 days ago and it may not be the diarrhea from the product. So, patient just wanted to know, what foods patient should eat to go over. What should patient eat so that patient do not get the diarrhea. patient think it may be if patient eat the right food, everything will be okay. Outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Residual pain in his arm pit- radiates to his neck and radiates down his arm to elbow
Pt recvd Hep B vax 7MAR90 & lab eval on 23OCT92 revealed anti-HBS pos, anti-HBC/IGG borderline, anti-HBE borderline, & HBEAG neg; pt also fatigue;
Upon administration of the vaccine to the left arm, the vaccinator inserted the needle and emptied the content from the syringe. Vaccinator noticed vaccine was leaking out from the side of the syringe/needle. Upon investigation, vaccinator realized that the certain syringe had two luer locks which the vaccine leaked out of the luer lock closest to the needle. Vaccinator was confident that 50% or all of the vaccine leaked out. Vaccinator checked with manager and policy guidelines to ensure the next step. A vaccine was then injected properly to the right arm.
Patient stated that she has previously gotten faint and passed out after getting immunizations. Patient was given crackers and juice before the injection.  Patient was alert and oriented until after the last injection (Men B) at which point she stated "I'm going to faint". This RN assisted the patient to a lying position on the couch where she was seated.  Patient lost consciousness for approximately 10 seconds, during which she became tense and slightly shaky.  The patient then regained consciousness and quickly sat upright, stating "I'm OK. Wow, that was a weird dream."  This RN was with the patient the entire time and remained with patient for 15 minutes after the event.  An M.D. was called to the room to assess the patient, vital signs were obtained, and patient was given more juice and crackers.  The patient remained at the facility for 15 more minutes and was determined to be safe to leave.
developed shingles; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15-JUN-2022, the patient received the 1st dose of Shingrix. On 01-DEC-2022, 169 days after receiving Shingrix, the patient experienced shingles (Verbatim: developed shingles). The outcome of the shingles was resolving.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK receipt date: 29-Mar-2023 The reporter reported that the patient received dose of Shingrix, and developed shingles.  The reporter said Shingles was still present but nearing the end in the patient.  The reporter did not have the lot number/ expiration date information for the Shingrix dose.  At the time of reporting, a second dose was not administered.  The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023047399:Same reporter/different patient
arm swelled up entire arm, itched all over, could not move arm;sick w/fever sx 1wk;
The vial was initially stored in the refrigerator on 11-Jul-2022 and was administered on 14-Jul-2022; Dose administered >12(US)/24(CA) hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered >12(US)/24(CA) hours post puncture) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jul-2022 and was administered on 14-Jul-2022) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered >12(US)/24(CA) hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jul-2022 and was administered on 14-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered >12(US)/24(CA) hours post puncture) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jul-2022 and was administered on 14-Jul-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided.  The vial was initially stored in the refrigerator on 11-Jul-2022.  The date and time of vial was first punctured on 13-Jul-2022 at 9:30 EST.  The vial was stored post puncture in Refrigerator.  The vial did not undergo any temperature excursion.  The patient received the Moderna Covid-19 vaccine booster dose and no side effects have been reported yet.  No treatment medication was provided.
During 24 hours following vacc:  Elevated temp 99.6-100.4 ;  Lasting for 72 hours: injection arm soreness and redness and warmth to the touch;  fatigue Starting 3/3/2021 red, itchy rash about 4? in diameter atinjection site
Following  day after vaccination she developed a sore arm, reddened area size of half a dollar at injection site, pain into scapular area, fatigue. The day after that tender axilla, fever (100.9*F), chills. Day after that bruised injection site, axilla sore and swollen, diaphoretic. 4 days after faint red injection site, tender axilla, feverish with intermittent chills. A week later continues to have a large, round welt, red in color at injection site, but all other symptoms have improved.
Patent received the  shot, was given a 15 minute timer until it was safe for him to leave, He went out and sat in the waiting room until his time was up. Approx, 10 minutes later I heard a noise and looked over at his and noticed he was started to fall out of his chair. He then became as stiff as a board and I held him in place until he came to. He was seemingly scared and not aware of his surroundings. He said that he was feeling better but was still light headed. He was given an icepack and water and took his mask off. He looked pale. He started to feel better and left approx 10 minutes after this happened. He told me that he was feeling dizzy before he passed out.
Shortly after the shot I had a big red lump on the area where the shot was administered. I then began feeling tired, my muscles hurt, I had ringing in my ears, I had what the doctor described as bells palsy, it seems as my symptoms just keep occuring in a circle. I suffered from anxiety attacks, lost weight, developed severe costochondritis. I finally got diagnosed with Fibromyalgia( autoimmune disorder)I was a healthy person before the shot now I'm always sick. I took the shot in 1997 and showed the localized red bump so the next year in Oct. 98 I told the doctor about the reaction the year prior and he said just go ahead and take it you'll be allright and since I worked at the hospital I had to take the flu shot. After that Oct. 98 date I've never been the same. I'm afraid to take the flu shot because I think I will have even a more violent reaction so I have not taken a flu shot since that day.
G47.33 OBSTRUCTIVE SLEEP APNEA 10/19/2021 SEPSIS UNSPECIFIED ORGANISM R09.02 HYPOXIA 11/8/2021 SEPSIS UNSPECIFIED ORGANISM
local redness; hard knot/plum size lump; vertigo; right arm tremor/shaking right hand; right side CV stiffening; headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Asthma, Aortic Valve Replacement, Cancer, Congenital heart disease NOS, Ventricular tachycardia and Pacemaker Insertion.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Further testing (nuclear test)
Patient had swelling in her face an hour after vaccination. Had pain in entire arm later due to reflex sympathetic dystrophy so went to exercise as she says that helps. During exercise had palpitations.  Face swelling has resolved and palpitations are improving markedly.
This spontaneous report as received from a medical assistant referring a current 1 year old male patient who was vaccinated with an expired dose 1 of M-M-R II, (lot # 667737/0603Z) (Expired date 23-APR-2012), right leg on 09-MAY-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effects were reported.
the side effect of headaches / severe headaches; crippling; This case was reported by a consumer and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. In February 2020, less than 2 months after receiving Shingles vaccine, the patient experienced headache and unable to walk. On an unknown date, the outcome of the headache and unable to walk were unknown.   It was unknown if the reporter considered the headache and unable to walk to be related to Shingles vaccine.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received the first injection of the shingles vaccine and on day of reporting patient experiencing severe headaches. It has been about six weeks till reporting and it was crippling the patient. The patient enquired how long does this side effect last or was there a treatment to counter react this side effect. The requesting consent to follow up.
DIZZINESS; This spontaneous report received from a patient concerned a 71 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, alcohol use, non-smoker, heart diseases, cholesterol, and blood pressure, and other pre-existing medical conditions included the patient was taking medications for heart diseases, cholesterol and blood pressure. The patient experienced drug allergy when treated with codeine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204821A, expiry: UNKNOWN) dose was not reported, administered on 28-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-MAY-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness. This report was non-serious. This case, from the same reporter is linked to 20210537307.
p/vax pt presented w/h/a that Md said sounds like a pan sinusitis but cannot be sure;MD did not given 2nd dose of vax;
This spontaneous prospective pregnancy case reported by a consumer, describes the occurrence of maternal exposure during pregnancy (she was 13 weeks pregnant) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 043B21A) for COVID-19 vaccination. No medical history reported. On Apr 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was Oct 16, 2021. On Apr 16, 2021, patient experienced maternal exposure during pregnancy (she is 13 weeks pregnant). On Apr 16, 2021, maternal exposure during pregnancy (she is 13 weeks pregnant) resolved. Diagnostic results: On Feb 7, 2021, pregnancy test: positive. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Mother reports 24 hrs after vaccination, noted redness and swelling of left arm. Child seen in ER where she was told it was an allergic reaction and to follow up with pediatrician. States child evaluated at physician's office on 02/13/2002 where swelling was measured at 7cm long and was told to give her Tylenol. Redness and swelling resolved.
bad headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (bad headaches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Intermittant fever starting 13SEP91 til 20SEP -21SEP; rash on face, trunk starting 21SEP; still present 8OCT; highest degree of fever measured 102;
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cranial nerve disorder since 23-Jun-2021 and Temporal arteritis since 23-Jun-2021.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FATIGUE (fatigue). On 04-Feb-2021, FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, Red blood cell sedimentation rate (0-30): normal (normal) 0-30 normal she was at 51.2. On an unknown date, C-reactive protein (0-6): normal (normal) 0-6 is normal she was at 52.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Patient received first vaccine on 03 FEB 2021. Patient felt fatigue right after her and stated the fatigue went away 1 day later. No treatment information was provided.   This case was linked to MOD-2021-245698 (Patient Link).
This spontaneous report was received from a vaccine coordinator referring to an unspecified number of patients whose on an unknown dates were vaccinated with improperly stored doses of ROTATEQ), (lots #s L033543, expiry date 30-MAY-2017; M034799, expiry date 01-FEB-2018 and M038744, expiry date 26-APR-2018). The vaccine was stored in refrigerator at a temperature of 47°F to 77°F (48 °F) for current excursion, but data not available for prior excursions. The time frame was 45 minutes. No previous temperature excursions were reported. No datalogger reported. No adverse effects reported. The outcome of incorrect product storage and no adverse event was unknown. This is one of five cases from the same reporter source, (linked to MARRS # 1704USA012566, 1704USA013566, 1704USA013567 and 1704USA013569). Additional information is not expected as no information to obtain follow up was provided.; Sender's Comments:  US-009507513-1704USA012566: US-009507513-1704USA013566: US-009507513-1704USA013567: US-009507513-1704USA013569:
Received vaccines (Flu and Pneumovax) 10/15/08. 10/16/08 Woke up with extreme lower back pain and joint pain. Also started with fever 103 F that day. Sick all day 10/16/08. 10/17/08 - Still had fever 99-100, nausea, clammy, joint pain. (L) arm local reaction. Red/hot/tender 3x5 inches. 10/18/08 Woke up with no problems - back to normal.
Next day dizziness, sweating, nausea - lasting 1 hr in the morning - feeling faint.
Initial and follow up information has been received from a licensed practical nurse concerning a 70 year old female patient with an allergy to sulfonamide and estrogen who on 13-DEC-2006 was vaccinated with the first dose of Pneumovax 23 (lot# 651374/0485F).  On an unspecified day the patient developed a localized reaction in her right upper arm with erythema and swelling and injection site rash.  The rash was described as a red welt at the injection site which was warm to the touch and painful.  The patient did not seek medical advice at the time of the reaction.  Subsequently, on 16-JAN-2007 the patient was examined in the physician's office and had recovered from the event.  A lot check was requested by the reporter.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements of the agency and was released.  Additional information has been requested.
Within 1-2hrs after vaccine, patient began sneezing repeatedly for the remainder of the day. Sore arm, chills, body aches, HA. Patient is breastfeeding. 24hr later, infant began rubbing bilateral eyes and has redness on skin bikaterally. No conjunctivitis. Eating w/o difficulty and otherwise acting fine. Did sleep longer than usual.
Patient is complaining about redness and swelling at the injection site. She said its very painful, red and swollen.
I started ovulating on the same day I received the second dose, 3/27/21.  On second night of the second dose, 3/28/21, I had swollen lymph nodes in left armpit, and experienced a tightness/heaviness in the chest. I had to sleep upright to get some sort of relief. The sensation would come and go throughout the coming days.   On 3/30/21, I was still experiencing the aforementioned symptoms, but was also now feeling dull pain in solar plexus and back (4 on a scale of 10). I took Tylenol.  On 4/5/21, I went to see my primary care physician. I had an EKG done, the results were 56 BPM, EKG Severity was borderline abnormal.  I never had a fever, diarrhea, chills. I only experienced left shoulder pain at the injection site, fatigue and a slight headache (which I expected).   Since then, the aforementioned symptoms have subsided, but I now experience tingling, numbness and a faint dull pain (1 or 2 on a scale of 10) in the left arm on the inside near my elbow?especially during night when I?m trying to sleep.
I believe the ringing in my ears which I am prone to has been exasperated since the vaccine.  The site where Moderna  injection was given has an outline in red and is swollen (was itchy)
Doctor told her it was an allergic reaction/bad allergic reaction; Such terrible hives; Rash was itchy; rash in different parts of her body, like torso, feet and it was terrible on her hands; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Such terrible hives), RASH PRURITIC (Rash was itchy), RASH (rash in different parts of her body, like torso, feet and it was terrible on her hands) and HYPERSENSITIVITY (Doctor told her it was an allergic reaction/bad allergic reaction) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Dec-2021, the patient experienced URTICARIA (Such terrible hives), RASH PRURITIC (Rash was itchy) and RASH (rash in different parts of her body, like torso, feet and it was terrible on her hands). On an unknown date, the patient experienced HYPERSENSITIVITY (Doctor told her it was an allergic reaction/bad allergic reaction). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (Such terrible hives), RASH PRURITIC (Rash was itchy), RASH (rash in different parts of her body, like torso, feet and it was terrible on her hands) and HYPERSENSITIVITY (Doctor told her it was an allergic reaction/bad allergic reaction) had resolved.            No concomitant medication reported.   This case was linked to MOD-2022-438991 (Patient Link).
Second covid-19 vaccine she got sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Second covid-19 vaccine she got sick) in a 74-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    The patient's past medical history included Surgery ("started in 1992".) in 1992. Concurrent medical conditions included Crohn's disease (Intestines out due to Crohn's disease in 2018.) since 2018.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Second covid-19 vaccine she got sick). At the time of the report, ILLNESS (Second covid-19 vaccine she got sick) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medication was provided by reporter.  No treatment drug was provided by reporter.   This case was linked to MOD-2022-587751 (Patient Link).   Reporter did not allow further contact